Resources

The right support to make a difference.


Integrate your medical expertise with our diagnostic tools.

Partnering with multi-disciplinary breast cancer care teams, we are working to overcome the complex challenges of early-stage breast cancer. Genomic testing is a fundamental tool as we approach each decision. It has the unique ability to illuminate an individual’s tumor biology and help guide more personalized treatment strategies.

We have designed our tests to deliver rapid results that you can leverage in patient consultations before and after surgery. Covered by most healthcare plans, they serve as part of our effort to ease financial burdens for patients and expand testing access around the globe.

U.S. Resources

Reports

Ordering form

Sample Reports

Mammaprint High Risk
Mammaprint low risk
Blueprint luminal

Instructions for Use

Specimen Collection Kit

Global Resources

Reports

Ordering Form

Sample Reports

Mammaprint High Risk
Mammaprint low risk
Blueprint luminal

Additional Global Information

Mammaprint Blueprint NGS kit

Included in Major International Guidelines

2020 NCCN Unbranded Guidelines

Download

ASCO – Breast Cancer Biomarkers

Download

2020 NCCN Unbranded Guidelines

Download

2020 NCCN Unbranded Guidelines

Download

St. Gallen Breast Cancer Guidelines

Download

Have more questions?

At Agendia, we are here to support you and your patients through the treatment planning process and beyond.

Billing & Financial Support
Licenses & Accreditations
Contact Customer Service

View upcoming events and conferences.

EVENTS >

Click here for a quick and easy ordering process.

ORDER A TEST >

Ordering MammaPrint and BluePrint is easy, and I am loving having this information so soon in the process because it helps the patient know what to expect.

– Suzanne Hoekstra, MD